Under the recently released Inpatient Prospective Payment System for fiscal year 2013, hospitals will not longer be reimbursed for CIED implantations that result in surgical site infections. The survey, conducted by Epocrates and sponsored by TYRX, polled 50 hospital CFOs at academic health centers and community hospitals across the United States to determine how hospital practices are likely to change as the result of the new CMS rule. Key findings include the following:
• 62 percent of CFOs consider the financial impact of the new payment rule on their hospital’s operations to be “very important.”
• Nearly all CFOs had adopted or plan to adopt new technologies to help reduce the risk of CIED infections.
• 82 percent of CFOs plan to use internal reporting measures to reduce the incidence of the CIED infections.
• 74 percent of CFOs believe their facilities may reduce the use of CIEDs when alternative therapies are available.
• Only 6 percent of hospital CFOs said their organization had not taken any actions to reduce the incidence of existing hospital-acquired conditions.
Learn more about TYRX.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
